| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.867 | 0.004 | 0.867 | Aldehyde oxidase inhibitor | 0.849 0.004 DBMET00802 | ||
| 0.749 | 0.018 | 0.749 | Caspase 9 stimulant | 0.64 0.031 DBMET00802 | ||
| 0.732 | 0.005 | 0.732 | Vasodilator, peripheral | 0.702 0.006 DBMET00802 | ||
| 0.711 | 0.004 | 0.711 | Histamine release inhibitor | 0.602 0.01 DBMET00802 | ||
| 0.704 | 0.004 | 0.704 | 5 Hydroxytryptamine release inhibitor | 0.647 0.006 DBMET00802 | ||
| 0.701 | 0.008 | 0.701 | Cholesterol antagonist | 0.644 0.013 DBMET00802 | ||
| 0.669 | 0.005 | 0.669 | Vasodilator, coronary | 0.573 0.009 DBMET00802 | ||
| 0.632 | 0.004 | 0.632 | P-glycoprotein inhibitor | 0.48 0.01 DBMET00802 | ||
| 0.63 | 0.012 | 0.63 | 5 Hydroxytryptamine release stimulant | 0.574 0.017 DBMET00802 | ||
| 0.621 | 0.004 | 0.621 | Amylase inhibitor | 0.434 0.008 DBMET00802 | ||
| 0.581 | 0.015 | 0.581 | Spasmolytic | 0.364 0.048 DBMET00802 | ||
| 0.545 | 0.004 | 0.545 | Alpha-N-acetylglucosaminidase inhibitor | 0.54 0.005 DBMET00802 | ||
| 0.516 | 0.008 | 0.522 | Peroxidase inhibitor | 0.522 0.008 DBMET00802 | DBMET00802 | |
| 0.501 | 0.006 | 0.501 | Cyclic AMP phosphodiesterase inhibitor | 0.349 0.026 DBMET00802 | ||
| 0.506 | 0.015 | 0.506 | Cardiotonic | 0.496 0.015 DBMET00802 | ||
| 0.495 | 0.012 | 0.495 | Vasodilator | 0.396 0.024 DBMET00802 | ||
| 0.485 | 0.004 | 0.485 | Expectorant | 0.472 0.004 DBMET00802 | ||
| 0.488 | 0.014 | 0.516 | Superoxide dismutase inhibitor | 0.516 0.011 DBMET00802 | DBMET00802 | |
| 0.454 | 0.005 | 0.454 | Insulin secretagoues | 0.305 0.012 DBMET00802 | ||
| 0.461 | 0.019 | 0.541 | Hypoglycemic | 0.541 0.012 DBMET00802 | DBMET00802 | |
| 0.479 | 0.039 | 0.499 | Immunosuppressant | 0.499 0.033 DBMET00802 | DBMET00802 | |
| 0.484 | 0.055 | 0.708 | Cyclophilin D inhibitor | 0.708 0.013 DBMET00802 | DBMET00802 | |
| 0.413 | 0.004 | 0.413 | Histone deacetylase stimulant | 0.072 0.053 DBMET00802 | ||
| 0.413 | 0.004 | 0.413 | Histone deacetylase SIRT1 stimulant | 0.072 0.053 DBMET00802 | ||
| 0.416 | 0.008 | 0.416 | Antiadrenergic | 0.26 0.017 DBMET00802 | ||
| 0.416 | 0.008 | 0.416 | Adrenaline antagonist | 0.258 0.016 DBMET00802 | ||
| 0.411 | 0.005 | 0.411 | Aldehyde dehydrogenase inhibitor | 0.33 0.009 DBMET00802 | ||
| 0.444 | 0.039 | 0.466 | Antithrombotic | 0.466 0.034 DBMET00802 | DBMET00802 | |
| 0.398 | 0.003 | 0.398 | Mucolytic | 0.389 0.003 DBMET00802 | ||
| 0.4 | 0.009 | 0.4 | DNA methyltransferase I inhibitor | 0.344 0.015 DBMET00802 | ||
| 0.413 | 0.025 | 0.413 | Tumour necrosis factor alpha release inhibitor | 0.204 0.105 DBMET00802 | ||
| 0.396 | 0.008 | 0.396 | Interleukin 6 antagonist | 0.22 0.031 DBMET00802 | ||
| 0.388 | 0.004 | 0.388 | Triose-phosphate isomerase inhibitor | 0.383 0.004 DBMET00802 | ||
| 0.393 | 0.027 | 0.421 | Calcium channel activator | 0.421 0.018 DBMET00802 | DBMET00802 | |
| 0.369 | 0.003 | 0.369 | Keratolytic | 0.252 0.005 DBMET00802 | ||
| 0.372 | 0.014 | 0.372 | DNA methylase inhibitor | 0.327 0.021 DBMET00802 | ||
| 0.381 | 0.024 | 0.402 | Sodium/bile acid cotransporter inhibitor | 0.402 0.016 DBMET00802 | DBMET00802 | |
| 0.359 | 0.004 | 0.53 | Alcohol oxidase inhibitor | 0.53 0.004 DBMET00802 | DBMET00802 | |
| 0.359 | 0.005 | 0.427 | Succinate dehydrogenase inhibitor | 0.427 0.004 DBMET00802 | DBMET00802 | |
| 0.348 | 0.008 | 0.348 | UDP-glucose 4-epimerase inhibitor | 0.225 0.015 DBMET00802 | ||
| 0.316 | 0.004 | 0.316 | Calcium antagonist | 0.222 0.011 DBMET00802 | ||
| 0.335 | 0.029 | 0.335 | Platelet aggregation inhibitor | 0.269 0.044 DBMET00802 | ||
| 0.327 | 0.027 | 0.327 | MAP kinase kinase 2 inhibitor | |||
| 0.325 | 0.028 | 0.334 | Anesthetic general | 0.334 0.026 DBMET00802 | DBMET00802 | |
| 0.321 | 0.024 | 0.321 | Non-steroidal antiinflammatory agent | 0.277 0.034 DBMET00802 | ||
| 0.315 | 0.024 | 0.315 | Gastrin inhibitor | 0.309 0.027 DBMET00802 | ||
| 0.348 | 0.06 | 0.348 | Caspase 3 stimulant | 0.346 0.06 DBMET00802 | ||
| 0.297 | 0.012 | 0.297 | Nitric-oxide synthase stimulant | 0.297 0.012 DBMET00802 | ||
| 0.292 | 0.013 | 0.292 | Anesthetic local | 0.2 0.032 DBMET00802 | ||
| 0.28 | 0.004 | 0.28 | Phenylalanine 4-hydroxylase inhibitor | 0.182 0.008 DBMET00802 | ||
| 0.281 | 0.007 | 0.283 | Mannose-6-phosphate isomerase inhibitor | 0.283 0.007 DBMET00802 | DBMET00802 | |
| 0.316 | 0.044 | 0.409 | Hypolipemic | 0.409 0.024 DBMET00802 | DBMET00802 | |
| 0.323 | 0.072 | 0.323 | Immunostimulant | 0.277 0.086 DBMET00802 | ||
| 0.266 | 0.015 | 0.328 | Cholesterol synthesis inhibitor | 0.328 0.009 DBMET00802 | DBMET00802 | |
| 0.274 | 0.023 | 0.413 | Insulin sensitizer | 0.413 0.005 DBMET00802 | DBMET00802 | |
| 0.306 | 0.063 | 0.306 | Hypoxia-inducible factor 1 alpha inhibitor | 0.241 0.109 DBMET00802 | ||
| 0.252 | 0.009 | 0.252 | Mediator release inhibitor | 0.157 0.026 DBMET00802 | ||
| 0.265 | 0.026 | 0.265 | Melanin inhibitor | 0.212 0.036 DBMET00802 | ||
| 0.299 | 0.062 | 0.421 | Antioxidant | 0.421 0.031 DBMET00802 | DBMET00802 | |
| 0.242 | 0.005 | 0.242 | Sphingomyelinase inhibitor | 0.178 0.015 DBMET00802 | ||
| 0.287 | 0.051 | 0.287 | Interleukin antagonist | 0.18 0.096 DBMET00802 | ||
| 0.275 | 0.041 | 0.275 | ErbB-1 antagonist | 0.235 0.06 DBMET00802 | ||
| 0.244 | 0.01 | 0.258 | Toll-Like receptor 2 antagonist | 0.258 0.008 DBMET00802 | DBMET00802 | |
| 0.246 | 0.014 | 0.246 | Interleukin 4 antagonist | 0.144 0.055 DBMET00802 | ||
| 0.247 | 0.016 | 0.247 | MAP kinase kinase inhibitor | |||
| 0.266 | 0.036 | 0.279 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.279 0.031 DBMET00802 | DBMET00802 | |
| 0.28 | 0.051 | 0.28 | DNA synthesis inhibitor | 0.254 0.064 DBMET00802 | ||
| 0.232 | 0.009 | 0.232 | NADH dehydrogenase inhibitor | 0.201 0.01 DBMET00802 | ||
| 0.278 | 0.058 | 0.312 | 5 Hydroxytryptamine uptake stimulant | 0.312 0.039 DBMET00802 | DBMET00802 | |
| 0.231 | 0.012 | 0.298 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.298 0.006 DBMET00802 | DBMET00802 | |
| 0.232 | 0.014 | 0.232 | Nav1.1 sodium channel blocker | 0.185 0.022 DBMET00802 | ||
| 0.241 | 0.026 | 0.241 | Phospholipase A2 inhibitor | 0.236 0.027 DBMET00802 | ||
| 0.243 | 0.028 | 0.255 | Protein kinase stimulant | 0.255 0.025 DBMET00802 | DBMET00802 | |
| 0.257 | 0.046 | 0.257 | Peptidyltransferase inhibitor | 0.24 0.058 DBMET00802 | ||
| 0.265 | 0.055 | 0.324 | Tyrosine 3 hydroxylase inhibitor | 0.324 0.023 DBMET00802 | DBMET00802 | |
| 0.219 | 0.012 | 0.324 | Catalase inhibitor | 0.324 0.005 DBMET00802 | DBMET00802 | |
| 0.215 | 0.008 | 0.227 | Adenylate cyclase stimulant | 0.227 0.006 DBMET00802 | DBMET00802 | |
| 0.3 | 0.094 | 0.331 | Transcription factor NF kappa B inhibitor | 0.331 0.083 DBMET00802 | DBMET00802 | |
| 0.344 | 0.138 | 0.344 | Alpha-glucosidase inhibitor | |||
| 0.27 | 0.065 | 0.299 | Interleukin agonist | 0.299 0.048 DBMET00802 | DBMET00802 | |
| 0.214 | 0.01 | 0.214 | Gastric antisecretory | 0.133 0.035 DBMET00802 | ||
| 0.208 | 0.004 | 0.208 | MAP kinase kinase 1 inhibitor | 0.093 0.066 DBMET00802 | ||
| 0.344 | 0.142 | 0.344 | Apoptosis agonist | 0.28 0.187 DBMET00802 | ||
| 0.217 | 0.016 | 0.217 | Interleukin 1b antagonist | 0.129 0.056 DBMET00802 | ||
| 0.22 | 0.023 | 0.22 | DNA polymerase I inhibitor | 0.136 0.057 DBMET00802 | ||
| 0.24 | 0.044 | 0.24 | Neurotrophic factor enhancer | 0.234 0.048 DBMET00802 | ||
| 0.252 | 0.059 | 0.252 | Antimitotic | |||
| 0.239 | 0.046 | 0.239 | Hepatoprotectant | 0.235 0.048 DBMET00802 | ||
| 0.212 | 0.022 | 0.219 | Arachidonic acid antagonist | 0.219 0.018 DBMET00802 | DBMET00802 | |
| 0.216 | 0.026 | 0.236 | ATPase inhibitor | 0.236 0.017 DBMET00802 | DBMET00802 | |
| 0.205 | 0.019 | 0.205 | Microtubule formation inhibitor | 0.196 0.021 DBMET00802 | ||
| 0.185 | 0.003 | 0.185 | Calcium channel P-type blocker | 0.146 0.003 DBMET00802 | ||
| 0.192 | 0.011 | 0.192 | Sphingosine 1-phosphate receptor 4 antagonist | 0.164 0.023 DBMET00802 | ||
| 0.214 | 0.036 | 0.232 | Interferon gamma antagonist | 0.232 0.032 DBMET00802 | DBMET00802 | |
| 0.205 | 0.028 | 0.205 | MAP kinase kinase 5 inhibitor | |||
| 0.349 | 0.173 | 0.349 | Antiinflammatory | |||
| 0.207 | 0.032 | 0.207 | Monophenol monooxygenase inhibitor | 0.185 0.037 DBMET00802 | ||
| 0.192 | 0.019 | 0.192 | Bronchodilator | 0.102 0.062 DBMET00802 | ||
| 0.207 | 0.034 | 0.207 | Bone formation stimulant | 0.157 0.053 DBMET00802 | ||
| 0.176 | 0.005 | 0.176 | Neuraminidase (influenza) inhibitor | 0.059 0.056 DBMET00802 | ||
| 0.188 | 0.017 | 0.188 | Topoisomerase II alpha inhibitor | 0.089 0.047 DBMET00802 | ||
| 0.174 | 0.004 | 0.174 | Sphingosine 1-phosphate receptor 3 agonist | 0.071 0.009 DBMET00802 | ||
| 0.187 | 0.02 | 0.187 | MAP kinase kinase 4 inhibitor | |||
| 0.193 | 0.027 | 0.193 | Nav1.3 sodium channel blocker | 0.124 0.069 DBMET00802 | ||
| 0.2 | 0.035 | 0.2 | Hexokinase inhibitor | 0.152 0.076 DBMET00802 | ||
| 0.183 | 0.021 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | 0.148 0.065 DBMET00802 | ||
| 0.186 | 0.025 | 0.208 | Cyclooxygenase 3 inhibitor | 0.208 0.016 DBMET00802 | DBMET00802 | |
| 0.244 | 0.084 | 0.244 | DNA damaging | 0.217 0.103 DBMET00802 | ||
| 0.225 | 0.066 | 0.225 | Amyloid beta aggregation inhibitor | 0.175 0.092 DBMET00802 | ||
| 0.17 | 0.015 | 0.29 | Phosphofructokinase-1 inhibitor | 0.29 0.006 DBMET00802 | DBMET00802 | |
| 0.224 | 0.069 | 0.224 | RNA-directed DNA polymerase inhibitor | 0.22 0.074 DBMET00802 | ||
| 0.192 | 0.037 | 0.192 | Nav1.2 sodium channel blocker | 0.117 0.086 DBMET00802 | ||
| 0.16 | 0.007 | 0.16 | Sphingosine 1-phosphate receptor 4 agonist | 0.123 0.016 DBMET00802 | ||
| 0.305 | 0.153 | 0.332 | Calcium channel L-type activator | 0.332 0.131 DBMET00802 | DBMET00802 | |
| 0.172 | 0.022 | 0.181 | Vanilloid 1 agonist | 0.181 0.018 DBMET00802 | DBMET00802 | |
| 0.154 | 0.005 | 0.154 | Neuraminidase inhibitor | |||
| 0.262 | 0.116 | 0.292 | Apoptosis antagonist | 0.292 0.091 DBMET00802 | DBMET00802 | |
| 0.238 | 0.093 | 0.322 | Transcription factor STAT3 inhibitor | 0.322 0.043 DBMET00802 | DBMET00802 | |
| 0.226 | 0.083 | 0.226 | Antiamyloidogenic | 0.173 0.12 DBMET00802 | ||
| 0.191 | 0.05 | 0.2 | Phospholipase C inhibitor | 0.2 0.044 DBMET00802 | DBMET00802 | |
| 0.162 | 0.021 | 0.162 | Ca2+-transporting ATPase inhibitor | 0.161 0.022 DBMET00802 | ||
| 0.157 | 0.017 | 0.166 | Toll-Like receptor 4 antagonist | 0.166 0.014 DBMET00802 | DBMET00802 | |
| 0.157 | 0.018 | 0.283 | Histidine decarboxylase inhibitor | 0.283 0.007 DBMET00802 | DBMET00802 | |
| 0.147 | 0.009 | 0.147 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.107 0.013 DBMET00802 | ||
| 0.147 | 0.01 | 0.147 | Phosphodiesterase 6D inhibitor | 0.119 0.026 DBMET00802 | ||
| 0.172 | 0.036 | 0.172 | Alkylator | 0.138 0.053 DBMET00802 | ||
| 0.154 | 0.018 | 0.154 | Electron transport complex I inhibitor | 0.14 0.027 DBMET00802 | ||
| 0.142 | 0.006 | 0.144 | Beta adrenoreceptor antagonist | 0.144 0.006 DBMET00802 | DBMET00802 | |
| 0.146 | 0.011 | 0.171 | Glutamate release inhibitor | 0.171 0.006 DBMET00802 | DBMET00802 | |
| 0.141 | 0.007 | 0.142 | Beta 3 adrenoreceptor antagonist | 0.142 0.006 DBMET00802 | DBMET00802 | |
| 0.192 | 0.058 | 0.192 | Tumour necrosis factor antagonist | 0.159 0.09 DBMET00802 | ||
| 0.217 | 0.085 | 0.262 | Free radical scavenger | 0.262 0.064 DBMET00802 | DBMET00802 | |
| 0.167 | 0.037 | 0.167 | Nav1.6 sodium channel blocker | 0.111 0.109 DBMET00802 | ||
| 0.176 | 0.046 | 0.176 | Tubulin antagonist | 0.142 0.062 DBMET00802 | ||
| 0.134 | 0.004 | 0.134 | Sphingosine 1-phosphate receptor agonist | 0.086 0.007 DBMET00802 | ||
| 0.154 | 0.025 | 0.222 | Adenylate kinase inhibitor | 0.222 0.012 DBMET00802 | DBMET00802 | |
| 0.181 | 0.053 | 0.181 | Diuretic | 0.138 0.087 DBMET00802 | ||
| 0.151 | 0.025 | 0.151 | Sphingosine 1-phosphate receptor 2 agonist | 0.123 0.05 DBMET00802 | ||
| 0.13 | 0.006 | 0.13 | Beta 1 adrenoreceptor antagonist | 0.126 0.006 DBMET00802 | ||
| 0.137 | 0.013 | 0.204 | Carbamoyl phosphate synthetase inhibitor | 0.204 0.007 DBMET00802 | DBMET00802 | |
| 0.16 | 0.036 | 0.232 | Cystathionine beta-synthase inhibitor | 0.232 0.018 DBMET00802 | DBMET00802 | |
| 0.169 | 0.048 | 0.169 | Cell wall synthesis inhibitor | 0.152 0.064 DBMET00802 | ||
| 0.139 | 0.018 | 0.139 | Adrenaline agonist | 0.134 0.02 DBMET00802 | ||
| 0.131 | 0.01 | 0.142 | Granulocyte macrophage colony stimulating factor agonist | 0.142 0.007 DBMET00802 | DBMET00802 | |
| 0.168 | 0.048 | 0.168 | Interleukin 1 antagonist | |||
| 0.126 | 0.007 | 0.126 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.049 0.044 DBMET00802 | ||
| 0.125 | 0.008 | 0.125 | Estrogen-related receptor beta agonist | 0.119 0.01 DBMET00802 | ||
| 0.119 | 0.004 | 0.135 | Glucose-6-phosphate isomerase inhibitor | 0.135 0.003 DBMET00802 | DBMET00802 | |
| 0.131 | 0.017 | 0.217 | Glutamate decarboxylase inhibitor | 0.217 0.005 DBMET00802 | DBMET00802 | |
| 0.174 | 0.06 | 0.174 | Cytidine deaminase inhibitor | 0.14 0.083 DBMET00802 | ||
| 0.128 | 0.015 | 0.133 | ATPase (Vacuolar H+) inhibitor | 0.133 0.013 DBMET00802 | DBMET00802 | |
| 0.135 | 0.023 | 0.135 | ErbB-3 antagonist | 0.075 0.067 DBMET00802 | ||
| 0.125 | 0.014 | 0.125 | Phosphodiesterase III inhibitor | 0.057 0.055 DBMET00802 | ||
| 0.116 | 0.006 | 0.116 | Phosphoglycerate kinase inhibitor | 0.098 0.007 DBMET00802 | ||
| 0.136 | 0.027 | 0.136 | Androgen antagonist | |||
| 0.11 | 0.004 | 0.11 | Sphingosine 1-phosphate receptor 1 agonist | 0.072 0.008 DBMET00802 | ||
| 0.164 | 0.057 | 0.169 | GABA C receptor rho-2 antagonist | 0.169 0.052 DBMET00802 | DBMET00802 | |
| 0.116 | 0.013 | 0.116 | Phosphodiesterase VI inhibitor | 0.081 0.04 DBMET00802 | ||
| 0.124 | 0.021 | 0.124 | Interleukin 5 antagonist | |||
| 0.132 | 0.031 | 0.153 | GABA C receptor rho-1 antagonist | 0.153 0.02 DBMET00802 | DBMET00802 | |
| 0.148 | 0.047 | 0.148 | Antibacterial (Helicobacter pylori) | 0.126 0.072 DBMET00802 | ||
| 0.117 | 0.016 | 0.154 | Leukotriene antagonist | 0.154 0.01 DBMET00802 | DBMET00802 | |
| 0.178 | 0.078 | 0.178 | Nitric oxide antagonist | 0.173 0.08 DBMET00802 | ||
| 0.105 | 0.006 | 0.105 | Alpha-mannosidase inhibitor | 0.101 0.006 DBMET00802 | ||
| 0.127 | 0.027 | 0.132 | Carbonic anhydrase XIII inhibitor | 0.132 0.026 DBMET00802 | DBMET00802 | |
| 0.11 | 0.011 | 0.127 | GABA B receptor agonist | 0.127 0.006 DBMET00802 | DBMET00802 | |
| 0.128 | 0.03 | 0.128 | Alcohol dehydrogenase inhibitor | 0.119 0.035 DBMET00802 | ||
| 0.102 | 0.005 | 0.102 | Mannosidase inhibitor | 0.096 0.006 DBMET00802 | ||
| 0.1 | 0.008 | 0.219 | Aconitate hydratase inhibitor | 0.219 0.003 DBMET00802 | DBMET00802 | |
| 0.126 | 0.037 | 0.126 | Creatine kinase inhibitor | 0.118 0.042 DBMET00802 | ||
| 0.097 | 0.008 | 0.097 | Epithelial sodium channel blocker | |||
| 0.128 | 0.039 | 0.14 | Carbonic anhydrase III inhibitor | 0.14 0.033 DBMET00802 | DBMET00802 | |
| 0.15 | 0.062 | 0.15 | Cytokine production inhibitor | 0.109 0.101 DBMET00802 | ||
| 0.127 | 0.038 | 0.127 | Acetylcholine release stimulant | 0.114 0.058 DBMET00802 | ||
| 0.096 | 0.008 | 0.096 | Beta 2 adrenoreceptor antagonist | 0.088 0.009 DBMET00802 | ||
| 0.145 | 0.058 | 0.149 | Heat shock protein 70 antagonist | 0.149 0.048 DBMET00802 | DBMET00802 | |
| 0.128 | 0.041 | 0.128 | Carbonic anhydrase XV inhibitor | 0.106 0.06 DBMET00802 | ||
| 0.12 | 0.033 | 0.12 | Phosphodiesterase IV inhibitor | |||
| 0.161 | 0.075 | 0.161 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.182 | 0.1 | 0.182 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.298 | 0.216 | 0.298 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.268 0.259 DBMET00802 | ||
| 0.088 | 0.007 | 0.093 | Lysophosphatidic acid 3 receptor antagonist | 0.093 0.006 DBMET00802 | DBMET00802 | |
| 0.112 | 0.032 | 0.12 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.12 0.029 DBMET00802 | DBMET00802 | |
| 0.12 | 0.039 | 0.12 | Breast cancer-resistant protein inhibitor | 0.118 0.04 DBMET00802 | ||
| 0.134 | 0.054 | 0.134 | Platelet activating factor antagonist | |||
| 0.215 | 0.135 | 0.267 | Insulysin inhibitor | 0.267 0.082 DBMET00802 | DBMET00802 | |
| 0.092 | 0.015 | 0.117 | Prostaglandin F2 alpha antagonist | 0.117 0.007 DBMET00802 | DBMET00802 | |
| 0.16 | 0.086 | 0.16 | 3C-like protease (Human coronavirus) inhibitor | 0.147 0.106 DBMET00802 | ||
| 0.125 | 0.051 | 0.148 | Photosensitizer | 0.148 0.032 DBMET00802 | DBMET00802 | |
| 0.103 | 0.029 | 0.103 | Na+ K+ transporting ATPase inhibitor | 0.082 0.049 DBMET00802 | ||
| 0.08 | 0.006 | 0.08 | Prostaglandin agonist | 0.069 0.008 DBMET00802 | ||
| 0.098 | 0.026 | 0.098 | Calcium channel L-type blocker | 0.072 0.049 DBMET00802 | ||
| 0.135 | 0.064 | 0.15 | Sphingosine 1-phosphate receptor 2 antagonist | 0.15 0.041 DBMET00802 | DBMET00802 | |
| 0.098 | 0.029 | 0.115 | Aminopeptidase I inhibitor | 0.115 0.021 DBMET00802 | DBMET00802 | |
| 0.176 | 0.107 | 0.197 | Angiogenesis stimulant | 0.197 0.096 DBMET00802 | DBMET00802 | |
| 0.119 | 0.05 | 0.152 | AMP-activated protein kinase stimulant | 0.152 0.027 DBMET00802 | DBMET00802 | |
| 0.073 | 0.004 | 0.073 | Guanylate cyclase inhibitor | 0.061 0.011 DBMET00802 | ||
| 0.12 | 0.052 | 0.136 | GABA C receptor antagonist | 0.136 0.039 DBMET00802 | DBMET00802 | |
| 0.129 | 0.061 | 0.129 | Topoisomerase II inhibitor | |||
| 0.12 | 0.053 | 0.152 | Aminopeptidase B inhibitor | 0.152 0.037 DBMET00802 | DBMET00802 | |
| 0.072 | 0.004 | 0.072 | Calcium-sensing receptor antagonist | 0.063 0.005 DBMET00802 | ||
| 0.071 | 0.004 | 0.071 | Uridine phosphorylase inhibitor | 0.048 0.009 DBMET00802 | ||
| 0.071 | 0.007 | 0.071 | Neuraminidase (Influenza A) inhibitor | |||
| 0.103 | 0.039 | 0.103 | ALK inhibitor | |||
| 0.068 | 0.004 | 0.068 | Vanilloid 3 antagonist | 0.062 0.005 DBMET00802 | ||
| 0.118 | 0.055 | 0.118 | Chelator | 0.1 0.077 DBMET00802 | ||
| 0.096 | 0.033 | 0.096 | Interferon agonist | 0.077 0.057 DBMET00802 | ||
| 0.067 | 0.005 | 0.067 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.022 DBMET00802 | ||
| 0.232 | 0.171 | 0.245 | GABA C receptor rho-3 antagonist | 0.245 0.158 DBMET00802 | DBMET00802 | |
| 0.271 | 0.211 | 0.271 | MAP kinase 1 inhibitor | |||
| 0.082 | 0.021 | 0.114 | Acyl-CoA dehydrogenase inhibitor | 0.114 0.013 DBMET00802 | DBMET00802 | |
| 0.098 | 0.039 | 0.124 | Glutathione S-transferase inhibitor | 0.124 0.021 DBMET00802 | DBMET00802 | |
| 0.092 | 0.034 | 0.092 | Purinergic P2X2 antagonist | |||
| 0.106 | 0.049 | 0.121 | Glutamate (mGluR7) agonist | 0.121 0.029 DBMET00802 | DBMET00802 | |
| 0.087 | 0.031 | 0.098 | Glycine receptor agonist | 0.098 0.022 DBMET00802 | DBMET00802 | |
| 0.059 | 0.004 | 0.06 | Prostaglandin F2 alpha agonist | 0.06 0.004 DBMET00802 | DBMET00802 | |
| 0.091 | 0.036 | 0.181 | Glutamate dehydrogenase inhibitor | 0.181 0.012 DBMET00802 | DBMET00802 | |
| 0.067 | 0.015 | 0.067 | Adenosine deaminase inhibitor | 0.053 0.027 DBMET00802 | ||
| 0.079 | 0.027 | 0.086 | Exportin-1 inhibitor | 0.086 0.018 DBMET00802 | DBMET00802 | |
| 0.103 | 0.053 | 0.134 | Electrolyte absorption antagonist | 0.134 0.027 DBMET00802 | DBMET00802 | |
| 0.069 | 0.019 | 0.073 | Ryanodine receptor antagonist | 0.073 0.014 DBMET00802 | DBMET00802 | |
| 0.109 | 0.059 | 0.122 | DOPA decarboxylase inhibitor | 0.122 0.043 DBMET00802 | DBMET00802 | |
| 0.105 | 0.055 | 0.114 | Anabolic | 0.114 0.045 DBMET00802 | DBMET00802 | |
| 0.055 | 0.005 | 0.055 | Cholesterol ester transfer protein antagonist | 0.042 0.011 DBMET00802 | ||
| 0.238 | 0.188 | 0.238 | Antibacterial | |||
| 0.069 | 0.02 | 0.106 | Leukotriene B4 antagonist | 0.106 0.009 DBMET00802 | DBMET00802 | |
| 0.065 | 0.017 | 0.065 | Squalene epoxidase inhibitor | 0.049 0.035 DBMET00802 | ||
| 0.069 | 0.021 | 0.069 | Beta 2 adrenoreceptor agonist | 0.064 0.034 DBMET00802 | ||
| 0.158 | 0.109 | 0.181 | Psychostimulant | 0.181 0.092 DBMET00802 | DBMET00802 | |
| 0.071 | 0.023 | 0.071 | Sphingosine kinase inhibitor | |||
| 0.066 | 0.018 | 0.07 | Leukotriene C antagonist | 0.07 0.014 DBMET00802 | DBMET00802 | |
| 0.194 | 0.147 | 0.272 | Transcription factor STAT inhibitor | 0.272 0.072 DBMET00802 | DBMET00802 | |
| 0.08 | 0.034 | 0.08 | Fibroblast growth factor 2 antagonist | |||
| 0.096 | 0.05 | 0.096 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.071 DBMET00802 | ||
| 0.075 | 0.029 | 0.136 | Prostaglandin EP2 antagonist | 0.136 0.012 DBMET00802 | DBMET00802 | |
| 0.077 | 0.031 | 0.096 | Glutamate (mGluR7) antagonist | 0.096 0.013 DBMET00802 | DBMET00802 | |
| 0.082 | 0.036 | 0.096 | Selectin antagonist | 0.096 0.029 DBMET00802 | DBMET00802 | |
| 0.109 | 0.064 | 0.109 | Protein kinase C gamma inhibitor | |||
| 0.091 | 0.047 | 0.091 | Platelet growth factor antagonist | |||
| 0.091 | 0.046 | 0.094 | Carbonic anhydrase VI inhibitor | 0.094 0.043 DBMET00802 | DBMET00802 | |
| 0.095 | 0.05 | 0.116 | Ornithine decarboxylase inhibitor | 0.116 0.029 DBMET00802 | DBMET00802 | |
| 0.14 | 0.096 | 0.14 | CF transmembrane conductance regulator agonist | 0.131 0.116 DBMET00802 | ||
| 0.048 | 0.005 | 0.048 | Sodium/glucose cotransporter inhibitor | |||
| 0.066 | 0.024 | 0.128 | Peroxisome proliferator-activated receptor alpha agonist | 0.128 0.008 DBMET00802 | DBMET00802 | |
| 0.105 | 0.062 | 0.175 | GABA C receptor agonist | 0.175 0.026 DBMET00802 | DBMET00802 | |
| 0.104 | 0.062 | 0.104 | Urease inhibitor | 0.095 0.072 DBMET00802 | ||
| 0.072 | 0.031 | 0.12 | Biliverdin reductase inhibitor | 0.12 0.014 DBMET00802 | DBMET00802 | |
| 0.066 | 0.025 | 0.066 | Sphingosine kinase 2 inhibitor | |||
| 0.053 | 0.013 | 0.054 | Beta adrenoreceptor agonist | 0.054 0.012 DBMET00802 | DBMET00802 | |
| 0.096 | 0.057 | 0.096 | Toll-Like receptor 3 antagonist | |||
| 0.045 | 0.007 | 0.045 | Prostaglandin EP2 agonist | 0.035 0.01 DBMET00802 | ||
| 0.084 | 0.046 | 0.099 | Macrophage migration inhibitory factor inhibitor | 0.099 0.035 DBMET00802 | DBMET00802 | |
| 0.067 | 0.029 | 0.067 | Sphingosine 1-phosphate receptor 3 antagonist | 0.057 0.043 DBMET00802 | ||
| 0.037 | 0.001 | 0.037 | Mannitol 2-dehydrogenase inhibitor | 0.01 0.004 DBMET00802 | ||
| 0.043 | 0.007 | 0.043 | Prostaglandin E2 agonist | 0.039 0.008 DBMET00802 | ||
| 0.062 | 0.026 | 0.062 | Pregnane X receptor antagonist | 0.061 0.029 DBMET00802 | ||
| 0.06 | 0.025 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.053 0.048 DBMET00802 | ||
| 0.045 | 0.01 | 0.052 | Lysophosphatidic acid 2 receptor antagonist | 0.052 0.008 DBMET00802 | DBMET00802 | |
| 0.185 | 0.15 | 0.185 | Neuropeptide Y2 antagonist | |||
| 0.039 | 0.006 | 0.039 | Lysophosphatidic acid receptor 1 agonist | 0.034 0.008 DBMET00802 | ||
| 0.047 | 0.014 | 0.118 | Fumarate hydratase inhibitor | 0.118 0.005 DBMET00802 | DBMET00802 | |
| 0.164 | 0.131 | 0.306 | Platelet antagonist | 0.306 0.051 DBMET00802 | DBMET00802 | |
| 0.193 | 0.16 | 0.193 | 12-Lipoxygenase inhibitor | 0.19 0.163 DBMET00802 | ||
| 0.07 | 0.038 | 0.07 | MDM2 inhibitor | 0.066 0.05 DBMET00802 | ||
| 0.058 | 0.028 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | 0.058 0.028 DBMET00802 | ||
| 0.117 | 0.088 | 0.117 | Sodium channel blocker | |||
| 0.095 | 0.066 | 0.095 | Platelet activating factor beta antagonist | |||
| 0.037 | 0.007 | 0.037 | Estrogen-related receptor gamma antagonist | |||
| 0.06 | 0.031 | 0.06 | Glucosylceramidase inhibitor | |||
| 0.059 | 0.03 | 0.059 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.042 | 0.014 | 0.042 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.042 0.014 DBMET00802 | ||
| 0.127 | 0.099 | 0.127 | MAP3K9 inhibitor | |||
| 0.069 | 0.041 | 0.089 | Glutamate (mGluR6) antagonist | 0.089 0.016 DBMET00802 | DBMET00802 | |
| 0.121 | 0.093 | 0.146 | Lipid peroxidase inhibitor | 0.146 0.071 DBMET00802 | DBMET00802 | |
| 0.184 | 0.158 | 0.228 | Lipoxygenase inhibitor | 0.228 0.116 DBMET00802 | DBMET00802 | |
| 0.113 | 0.087 | 0.117 | DNA repair enzyme inhibitor | 0.117 0.079 DBMET00802 | DBMET00802 | |
| 0.144 | 0.117 | 0.17 | Neurotensin receptor agonist | 0.17 0.063 DBMET00802 | DBMET00802 | |
| 0.034 | 0.008 | 0.034 | Hedgehog signaling activator | 0.029 0.014 DBMET00802 | ||
| 0.029 | 0.004 | 0.029 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET00802 | ||
| 0.112 | 0.086 | 0.121 | Cathepsin H inhibitor | 0.121 0.074 DBMET00802 | DBMET00802 | |
| 0.056 | 0.031 | 0.065 | Heparanase inhibitor | 0.065 0.016 DBMET00802 | DBMET00802 | |
| 0.032 | 0.007 | 0.032 | Vitamin D receptor antagonist | |||
| 0.055 | 0.03 | 0.055 | Vanilloid 2 antagonist | 0.049 0.044 DBMET00802 | ||
| 0.039 | 0.015 | 0.048 | HMG CoA reductase inhibitor | 0.048 0.008 DBMET00802 | DBMET00802 | |
| 0.046 | 0.022 | 0.046 | Plasmepsin II inhibitor | 0.04 0.03 DBMET00802 | ||
| 0.083 | 0.059 | 0.089 | D-Ala-D-Ala ligase inhibitor | 0.089 0.046 DBMET00802 | DBMET00802 | |
| 0.029 | 0.005 | 0.029 | Ileal bile acid transport inhibitor | 0.023 0.007 DBMET00802 | ||
| 0.077 | 0.054 | 0.077 | MAP kinase kinase 7 inhibitor | |||
| 0.027 | 0.004 | 0.027 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET00802 | ||
| 0.045 | 0.023 | 0.045 | Sphingosine kinase 1 inhibitor | |||
| 0.114 | 0.092 | 0.114 | Sodium channel (voltage-gated) blocker | |||
| 0.091 | 0.07 | 0.151 | Xanthine oxidase inhibitor | 0.151 0.034 DBMET00802 | DBMET00802 | |
| 0.042 | 0.02 | 0.045 | Leukotriene C4 antagonist | 0.045 0.015 DBMET00802 | DBMET00802 | |
| 0.048 | 0.027 | 0.048 | Phosphodiesterase 3B inhibitor | |||
| 0.064 | 0.044 | 0.064 | Interferon inducer | 0.059 0.057 DBMET00802 | ||
| 0.028 | 0.007 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 DBMET00802 | ||
| 0.055 | 0.035 | 0.07 | Ornithine carbamoyltransferase inhibitor | 0.07 0.026 DBMET00802 | DBMET00802 | |
| 0.025 | 0.004 | 0.025 | Vitamin D receptor agonist | 0.018 0.009 DBMET00802 | ||
| 0.06 | 0.04 | 0.06 | Heat shock protein 90 beta antagonist | |||
| 0.203 | 0.184 | 0.263 | Interleukin 2 agonist | 0.263 0.105 DBMET00802 | DBMET00802 | |
| 0.088 | 0.069 | 0.095 | Prolactin inhibitor | 0.095 0.061 DBMET00802 | DBMET00802 | |
| 0.042 | 0.023 | 0.045 | GABA uptake inhibitor | 0.045 0.02 DBMET00802 | DBMET00802 | |
| 0.087 | 0.069 | 0.114 | HIV-1 integrase (Overall Integration) inhibitor | 0.114 0.043 DBMET00802 | DBMET00802 | |
| 0.113 | 0.096 | 0.113 | Calcium channel blocker | |||
| 0.082 | 0.064 | 0.082 | mTOR complex 2 inhibitor | |||
| 0.034 | 0.017 | 0.042 | Glutamate (mGluR3) agonist | 0.042 0.008 DBMET00802 | DBMET00802 | |
| 0.094 | 0.077 | 0.094 | Falcipain 3 inhibitor | |||
| 0.027 | 0.011 | 0.027 | Beta 1 adrenoreceptor agonist | 0.025 0.012 DBMET00802 | ||
| 0.082 | 0.066 | 0.082 | Vanilloid agonist | 0.082 0.064 DBMET00802 | ||
| 0.036 | 0.02 | 0.102 | Peroxisome proliferator-activated receptor delta agonist | 0.102 0.005 DBMET00802 | DBMET00802 | |
| 0.035 | 0.02 | 0.035 | Melatonin receptor 1A agonist | |||
| 0.128 | 0.113 | 0.128 | MAP kinase 3 inhibitor | |||
| 0.063 | 0.048 | 0.063 | Aryl hydrocarbon receptor antagonist | |||
| 0.056 | 0.042 | 0.056 | Beta tubulin antagonist | 0.05 0.047 DBMET00802 | ||
| 0.089 | 0.076 | 0.089 | Protease inhibitor | 0.087 0.078 DBMET00802 | ||
| 0.043 | 0.03 | 0.043 | Heme oxygenase inhibitor | 0.041 0.036 DBMET00802 | ||
| 0.058 | 0.046 | 0.068 | Purinergic P2X1 antagonist | 0.068 0.034 DBMET00802 | DBMET00802 | |
| 0.073 | 0.061 | 0.073 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.031 | 0.02 | 0.044 | Prostaglandin D2 agonist | 0.044 0.01 DBMET00802 | DBMET00802 | |
| 0.023 | 0.012 | 0.031 | Lysophosphatidic acid 1 receptor antagonist | 0.031 0.006 DBMET00802 | DBMET00802 | |
| 0.047 | 0.037 | 0.051 | Bombesin 2 receptor antagonist | 0.051 0.033 DBMET00802 | DBMET00802 | |
| 0.084 | 0.074 | 0.084 | Polo-like kinase-1 inhibitor | |||
| 0.092 | 0.083 | 0.092 | Beta glucuronidase inhibitor | |||
| 0.07 | 0.061 | 0.087 | GABA aminotransferase inhibitor | 0.087 0.038 DBMET00802 | DBMET00802 | |
| 0.046 | 0.038 | 0.046 | Metalloproteinase-3 inhibitor | 0.046 0.038 DBMET00802 | ||
| 0.05 | 0.041 | 0.05 | Alpha tubulin antagonist | |||
| 0.032 | 0.023 | 0.032 | Estrogen-related receptor beta antagonist | |||
| 0.027 | 0.018 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.027 | 0.02 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.061 | 0.054 | 0.061 | Acetylcholine M5 receptor agonist | |||
| 0.098 | 0.092 | 0.106 | Beta amyloid protein antagonist | 0.106 0.083 DBMET00802 | DBMET00802 | |
| 0.039 | 0.034 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.034 DBMET00802 | DBMET00802 | |
| 0.065 | 0.06 | 0.065 | Secretase beta inhibitor | |||
| 0.036 | 0.032 | 0.048 | Glutamate (mGluR8) agonist | 0.048 0.013 DBMET00802 | DBMET00802 | |
| 0.083 | 0.08 | 0.083 | Protein kinase C zeta inhibitor | |||
| 0.037 | 0.035 | 0.037 | Thymidine kinase inhibitor | |||
| 0.066 | 0.064 | 0.1 | Peroxisome proliferator-activated receptor gamma antagonist | 0.1 0.015 DBMET00802 | DBMET00802 | |
| 0.036 | 0.034 | 0.036 | Toll-Like receptor 2 agonist | |||
| 0.06 | 0.058 | 0.347 | Peroxisome proliferator-activated receptor gamma agonist | 0.347 0.004 DBMET00802 | DBMET00802 | |
| 0.086 | 0.085 | 0.086 | Insulin receptor antagonist | |||
| 0.031 | 0.03 | 0.031 | Renin inhibitor | |||
| 0.01 | 0.009 | 0.014 | Thromboxane agonist | 0.014 0.005 DBMET00802 | DBMET00802 | |
| 0.025 | 0.024 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.023 DBMET00802 | ||
| 0.042 | 0.043 | 0.047 | Carbonic anhydrase XIV inhibitor | 0.047 0.037 DBMET00802 | DBMET00802 | |
| 0.032 | 0.034 | 0.051 | Glutamate (mGluR3) antagonist | 0.051 0.012 DBMET00802 | DBMET00802 | |
| 0.017 | 0.018 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.011 DBMET00802 | DBMET00802 | |
| 0.03 | 0.032 | 0.041 | Carnitine palmitoyltransferase 1 inhibitor | 0.041 0.015 DBMET00802 | DBMET00802 | |
| 0.085 | 0.087 | 0.098 | Bile acid receptor antagonist | 0.098 0.054 DBMET00802 | DBMET00802 | |
| 0.013 | 0.017 | 0.022 | G-protein-coupled receptor 120 agonist | 0.022 0.008 DBMET00802 | DBMET00802 | |
| 0.117 | 0.121 | 0.126 | Hemostatic | 0.126 0.103 DBMET00802 | DBMET00802 | |
| 0.013 | 0.017 | 0.017 | Thromboxane A2 agonist | 0.017 0.009 DBMET00802 | DBMET00802 | |
| 0.01 | 0.014 | 0.037 | Prostaglandin EP4 agonist | 0.037 0.006 DBMET00802 | DBMET00802 | |
| 0.012 | 0.016 | 0.025 | Prostacyclin agonist | 0.025 0.007 DBMET00802 | DBMET00802 | |
| 0.029 | 0.034 | 0.041 | Carnitine palmitoyltransferase inhibitor | 0.041 0.015 DBMET00802 | DBMET00802 | |
| 0.008 | 0.013 | 0.011 | Beta 3 adrenoreceptor agonist | 0.011 0.008 DBMET00802 | DBMET00802 | |
| 0.045 | 0.051 | 0.064 | Xanthine dehydrogenase inhibitor | 0.064 0.035 DBMET00802 | DBMET00802 | |
| 0.026 | 0.032 | 0.035 | Thiazolidinedione | 0.035 0.012 DBMET00802 | DBMET00802 | |
| 0.032 | 0.04 | 0.037 | Dihydropteroate synthase inhibitor | 0.037 0.03 DBMET00802 | DBMET00802 | |
| 0.037 | 0.045 | 0.048 | Carbonic anhydrase VII inhibitor | 0.048 0.03 DBMET00802 | DBMET00802 | |
| 0.027 | 0.036 | 0.043 | Free fatty acid receptor 1 antagonist | 0.043 0.013 DBMET00802 | DBMET00802 | |
| 0.093 | 0.104 | 0.115 | Caspase 3 inhibitor | 0.115 0.067 DBMET00802 | DBMET00802 | |
| 0.053 | 0.063 | 0.072 | Nitric oxide donor | 0.072 0.03 DBMET00802 | DBMET00802 | |
| 0.019 | 0.03 | 0.061 | Kynurenine 3 monooxygenase inhibitor | 0.061 0.005 DBMET00802 | DBMET00802 | |
| 0.127 | 0.14 | 0.234 | Pyruvate kinase inhibitor | 0.234 0.066 DBMET00802 | DBMET00802 | |
| 0.011 | 0.025 | 0.016 | Carbonic anhydrase X inhibitor | 0.016 0.012 DBMET00802 | DBMET00802 | |
| 0.011 | 0.025 | 0.016 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 DBMET00802 | DBMET00802 | |
| 0.035 | 0.05 | 0.047 | Kainate receptor agonist | 0.047 0.018 DBMET00802 | DBMET00802 | |
| 0.046 | 0.061 | 0.06 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.06 0.039 DBMET00802 | DBMET00802 | |
| 0.052 | 0.069 | 0.079 | Leukotriene synthesis inhibitor | 0.079 0.038 DBMET00802 | DBMET00802 | |
| 0.073 | 0.09 | 0.08 | Transcription factor NF kappa B stimulant | 0.08 0.071 DBMET00802 | DBMET00802 | |
| 0.01 | 0.027 | 0.016 | Free fatty acid receptor 1 agonist | 0.016 0.014 DBMET00802 | DBMET00802 | |
| 0.042 | 0.06 | 0.059 | Glucose-6-phosphate translocase inhibitor | 0.059 0.024 DBMET00802 | DBMET00802 | |
| 0.056 | 0.076 | 0.088 | Antineoplastic antibiotic | 0.088 0.052 DBMET00802 | DBMET00802 | |
| 0.017 | 0.037 | 0.037 | Prostaglandin EP4 antagonist | 0.037 0.012 DBMET00802 | DBMET00802 | |
| 0.041 | 0.063 | 0.065 | CD45 antagonist | 0.065 0.018 DBMET00802 | DBMET00802 | |
| 0.009 | 0.032 | 0.026 | Endothelin B receptor antagonist | 0.026 0.01 DBMET00802 | DBMET00802 | |
| 0.023 | 0.046 | 0.041 | ATP citrate lysase inhibitor | 0.041 0.012 DBMET00802 | DBMET00802 | |
| 0.016 | 0.041 | 0.036 | Squalene synthetase inhibitor | 0.036 0.02 DBMET00802 | DBMET00802 | |
| 0.019 | 0.043 | 0.062 | Prostacyclin antagonist | 0.062 0.009 DBMET00802 | DBMET00802 | |
| 0.014 | 0.039 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.019 DBMET00802 | DBMET00802 | |
| 0.015 | 0.041 | 0.027 | Leukotriene D4 antagonist | 0.027 0.018 DBMET00802 | DBMET00802 | |
| 0.015 | 0.042 | 0.035 | Leukotriene B4 receptor 1 antagonist | 0.035 0.015 DBMET00802 | DBMET00802 | |
| 0.032 | 0.06 | 0.047 | Glucagon-like peptide 1 receptor antagonist | 0.047 0.016 DBMET00802 | DBMET00802 | |
| 0.038 | 0.067 | 0.045 | Topoisomerase II beta inhibitor | 0.045 0.041 DBMET00802 | DBMET00802 | |
| 0.117 | 0.149 | 0.166 | Platelet adhesion inhibitor | 0.166 0.091 DBMET00802 | DBMET00802 | |
| 0.011 | 0.045 | 0.024 | Prostaglandin H2 antagonist | 0.024 0.019 DBMET00802 | DBMET00802 | |
| 0.036 | 0.073 | 0.062 | Argininosuccinate synthase inhibitor | 0.062 0.035 DBMET00802 | DBMET00802 | |
| 0.023 | 0.061 | 0.106 | Peroxisome proliferator-activated receptor delta antagonist | 0.106 0.005 DBMET00802 | DBMET00802 | |
| 0.085 | 0.123 | 0.098 | TRPA1 agonist | 0.098 0.092 DBMET00802 | DBMET00802 | |
| 0.006 | 0.045 | 0.031 | Peroxisome proliferator-activated receptor alpha antagonist | 0.031 0.011 DBMET00802 | DBMET00802 | |
| 0.04 | 0.082 | 0.054 | Thromboxane synthase inhibitor | 0.054 0.038 DBMET00802 | DBMET00802 | |
| 0.075 | 0.118 | 0.089 | Interleukin 12 antagonist | 0.089 0.075 DBMET00802 | DBMET00802 | |
| 0.032 | 0.078 | 0.046 | Glutamate (mGluR group III) antagonist | 0.046 0.027 DBMET00802 | DBMET00802 | |
| 0.013 | 0.06 | 0.037 | Endothelin receptor antagonist | 0.037 0.013 DBMET00802 | DBMET00802 | |
| 0.025 | 0.075 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.024 DBMET00802 | DBMET00802 | |
| 0.018 | 0.069 | 0.031 | Retinoid X alpha receptor agonist | 0.031 0.029 DBMET00802 | DBMET00802 | |
| 0.015 | 0.067 | 0.044 | Retinoid X receptor agonist | 0.044 0.02 DBMET00802 | DBMET00802 | |
| 0.043 | 0.098 | 0.062 | Adenine nucleotide translocase inhibitor | 0.062 0.025 DBMET00802 | DBMET00802 | |
| 0.011 | 0.066 | 0.033 | Prostaglandin EP3 antagonist | 0.033 0.019 DBMET00802 | DBMET00802 | |
| 0.044 | 0.1 | 0.083 | Porphobilinogen synthase inhibitor | 0.083 0.045 DBMET00802 | DBMET00802 | |
| 0.067 | 0.126 | 0.117 | Ferrochelatase inhibitor | 0.117 0.056 DBMET00802 | DBMET00802 | |
| 0.026 | 0.09 | 0.056 | Thromboxane antagonist | 0.056 0.036 DBMET00802 | DBMET00802 | |
| 0.023 | 0.087 | 0.053 | Thromboxane A2 antagonist | 0.053 0.033 DBMET00802 | DBMET00802 | |
| 0.008 | 0.074 | 0.024 | Endothelin A receptor antagonist | 0.024 0.012 DBMET00802 | DBMET00802 | |
| 0.031 | 0.099 | 0.066 | NMDA receptor glycine site agonist | 0.066 0.04 DBMET00802 | DBMET00802 | |
| 0.029 | 0.098 | 0.046 | Carnitine palmitoyltransferase 1B inhibitor | 0.046 0.037 DBMET00802 | DBMET00802 | |
| 0.062 | 0.132 | 0.219 | Protein-tyrosine phosphatase 1B inhibitor | 0.219 0.024 DBMET00802 | DBMET00802 | |
| 0.097 | 0.173 | 0.143 | Growth hormone agonist | 0.143 0.093 DBMET00802 | DBMET00802 | |
| 0.026 | 0.103 | 0.119 | Plasminogen activator inhibitor antagonist | 0.119 0.007 DBMET00802 | DBMET00802 | |
| 0.059 | 0.138 | 0.083 | Uric acid excretion stimulant | 0.083 0.077 DBMET00802 | DBMET00802 | |
| 0.075 | 0.173 | 0.128 | Cell adhesion inhibitor | 0.128 0.06 DBMET00802 | DBMET00802 | |
| 0.06 | 0.167 | 0.085 | Interleukin 1 beta converting enzyme inhibitor | 0.085 0.081 DBMET00802 | DBMET00802 | |
| 0.05 | 0.159 | 0.087 | Cell adhesion molecule inhibitor | 0.087 0.045 DBMET00802 | DBMET00802 | |
| 0.078 | 0.194 | 0.249 | Protein-tyrosine phosphatase inhibitor | 0.249 0.031 DBMET00802 | DBMET00802 | |
| 0.017 | 0.14 | 0.053 | Aldose reductase inhibitor | 0.053 0.037 DBMET00802 | DBMET00802 | |
| 0.028 | 0.153 | 0.065 | HIV-1 integrase (3'-Processing) inhibitor | 0.065 0.043 DBMET00802 | DBMET00802 | |
| 0.022 | 0.149 | 0.063 | HIV-1 integrase (Strand Transfer) inhibitor | 0.063 0.04 DBMET00802 | DBMET00802 | |
| 0.067 | 0.198 | 0.093 | Folate antagonist | 0.093 0.079 DBMET00802 | DBMET00802 | |
| 0.055 | 0.19 | 0.097 | ABCA1 expression enhancer | 0.097 0.054 DBMET00802 | DBMET00802 | |
| 0.06 | 0.202 | 0.227 | Thrombolytic | 0.227 0.04 DBMET00802 | DBMET00802 | |
| 0.032 | 0.186 | 0.06 | DNA helicase inhibitor | 0.06 0.028 DBMET00802 | DBMET00802 | |
| 0.014 | 0.183 | 0.064 | Prostaglandin antagonist | 0.064 0.029 DBMET00802 | DBMET00802 | |
| 0.092 | 0.266 | 0.16 | Lipocortins synthesis antagonist | 0.16 0.092 DBMET00802 | DBMET00802 | |
| 0.034 | 0.208 | 0.064 | HIV-1 integrase inhibitor | 0.064 0.059 DBMET00802 | DBMET00802 | |
| 0.081 | 0.416 | 0.314 | Antiobesity | 0.314 0.107 DBMET00802 | DBMET00802 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |